ENTO
Price
$0.48
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
2.28M
IMMP
Price
$1.72
Change
+$0.02 (+1.18%)
Updated
Jul 25 closing price
Capitalization
249.78M
32 days until earnings call
Interact to see
Advertisement

ENTO vs IMMP

Header iconENTO vs IMMP Comparison
Open Charts ENTO vs IMMPBanner chart's image
Entero Therapeutics
Price$0.48
Change-$0.00 (-0.00%)
Volume$50.28K
Capitalization2.28M
Immutep
Price$1.72
Change+$0.02 (+1.18%)
Volume$52.58K
Capitalization249.78M
ENTO vs IMMP Comparison Chart in %
Loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTO vs. IMMP commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTO is a StrongBuy and IMMP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ENTO: $0.48 vs. IMMP: $1.72)
Brand notoriety: ENTO and IMMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTO: 2% vs. IMMP: 61%
Market capitalization -- ENTO: $2.28M vs. IMMP: $249.78M
ENTO [@Biotechnology] is valued at $2.28M. IMMP’s [@Biotechnology] market capitalization is $249.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTO’s FA Score shows that 1 FA rating(s) are green whileIMMP’s FA Score has 0 green FA rating(s).

  • ENTO’s FA Score: 1 green, 4 red.
  • IMMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTO is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTO’s TA Score shows that 5 TA indicator(s) are bullish while IMMP’s TA Score has 5 bullish TA indicator(s).

  • ENTO’s TA Score: 5 bullish, 3 bearish.
  • IMMP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ENTO is a better buy in the short-term than IMMP.

Price Growth

ENTO (@Biotechnology) experienced а +1.31% price change this week, while IMMP (@Biotechnology) price change was +1.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ENTO is expected to report earnings on May 15, 2025.

IMMP is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMP($250M) has a higher market cap than ENTO($2.28M). IMMP YTD gains are higher at: -20.737 vs. ENTO (-22.990). ENTO has higher annual earnings (EBITDA): -7.42M vs. IMMP (-43.83M). IMMP has more cash in the bank: 159M vs. ENTO (59.4K). ENTO has less debt than IMMP: ENTO (836K) vs IMMP (1.69M). ENTO (0) and IMMP (0) have equivalent revenues.
ENTOIMMPENTO / IMMP
Capitalization2.28M250M1%
EBITDA-7.42M-43.83M17%
Gain YTD-22.990-20.737111%
P/E Ratio0.03N/A-
Revenue00-
Total Cash59.4K159M0%
Total Debt836K1.69M50%
FUNDAMENTALS RATINGS
ENTO vs IMMP: Fundamental Ratings
ENTO
IMMP
OUTLOOK RATING
1..100
907
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
5659
P/E GROWTH RATING
1..100
90100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENTO's Valuation (9) in the null industry is significantly better than the same rating for IMMP (83) in the Biotechnology industry. This means that ENTO’s stock grew significantly faster than IMMP’s over the last 12 months.

IMMP's Profit vs Risk Rating (85) in the Biotechnology industry is in the same range as ENTO (100) in the null industry. This means that IMMP’s stock grew similarly to ENTO’s over the last 12 months.

IMMP's SMR Rating (96) in the Biotechnology industry is in the same range as ENTO (100) in the null industry. This means that IMMP’s stock grew similarly to ENTO’s over the last 12 months.

ENTO's Price Growth Rating (56) in the null industry is in the same range as IMMP (59) in the Biotechnology industry. This means that ENTO’s stock grew similarly to IMMP’s over the last 12 months.

ENTO's P/E Growth Rating (90) in the null industry is in the same range as IMMP (100) in the Biotechnology industry. This means that ENTO’s stock grew similarly to IMMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTOIMMP
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTEX30.700.49
+1.62%
Open Text Corp
CNDT2.780.02
+0.72%
Conduent
EDBL2.61-0.03
-1.14%
Edible Garden AG Incorporated
NEO6.29-0.13
-2.02%
NeoGenomics
WIMI4.14-0.11
-2.59%
WiMi Hologram Cloud Inc

ENTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTO has been loosely correlated with IVVD. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTO jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTO
1D Price
Change %
ENTO100%
-1.05%
IVVD - ENTO
60%
Loosely correlated
-3.09%
FBLG - ENTO
38%
Loosely correlated
+3.06%
RLMD - ENTO
35%
Loosely correlated
-2.78%
CABA - ENTO
30%
Poorly correlated
N/A
IMMP - ENTO
29%
Poorly correlated
+1.18%
More